Joyce Ohm, PhD

Dr Joyce Ohm on the future of cancer care: identifying molecular drivers in every tumor to develop truly individualized, targeted therapies.

Dr Joyce Ohm discusses the ethical questions raised by genome sequencing, from data ownership to reporting mutations of unknown significance.

Dr Joyce Ohm explains how sequencing tumor genomes reveals the mutations needed to design targeted cell and gene therapies for cancer patients.

Joyce Ohm, PhD, explains how fast genome sequencing now drives targeted cancer therapies, revealing mutations and resistance in real time.

Genome sequencing speeds tumor mutation discovery, boosting targeted cancer therapies and cell/gene treatments while raising urgent questions about data ownership, reporting uncertainty, and ethics.